- FDA Statement of Identity
- Rx Only Dietary Supplement
- FDA Statement of Identity
- Description: PNV-DHA is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is cobalt blue in color, opaque, and imprinted with "BP321" on one side and blank on the other. PNV-DHA can also be beneficial in improving the nutritional status of women prior to conception.
- Precautions re: Allergies
- PNV-DHA contains fish oil and soy.
- Formula re: Type
- Indications: PNV-DHA is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.
- Precautions re: All Other
- Contraindications: PNV-DHA is contraindicated in patients with a known hypersensivity to any of the ingredients.
- Precautions re: All Other
- Warning: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR).
- Precautions re: Pregnant or Nursing or Prescription Medications
- Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited and acquired predisposition to bleeding.
- Precautions re: All Other
- Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
- Precautions re: Children
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.